-
Mashup Score: 17
CMG901 showed a manageable safety profile and had promising antitumour activity in patients with advanced gastric or gastro-oesophageal junction cancer.
Source: www.thelancet.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 17
CMG901 showed a manageable safety profile and had promising antitumour activity in patients with advanced gastric or gastro-oesophageal junction cancer.
Source: www.thelancet.comCategories: General Medicine News, Oncologists1Tweet-
New Research: #Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced #gastric or gastro-oesophageal junction #GEJ #cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial #gicsm https://t.co/kykMD2R2K1
-
New Research: #Claudin 18.2-targeting antibody–drug conjugate CMG901 in patients with advanced #gastric or gastro-oesophageal junction #GEJ #cancer (KYM901): a multicentre, open-label, single-arm, phase 1 trial #gicsm https://t.co/kykMD2R2K1